Ignite Creation Date:
2025-12-24 @ 11:58 AM
Ignite Modification Date:
2025-12-25 @ 12:56 PM
Study NCT ID:
NCT05896761
Status:
COMPLETED
Last Update Posted:
2023-09-18
First Post:
2023-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants
Sponsor:
ViiV Healthcare
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Human Immunodeficiency Virus Type 1 (HIV-1) | View |